Harmless medicines? Indian pharma fuels Africa’s ‘zombie drug’ and opioid crisis
An officer holds seized red Tapentadol tablets at the National Drug Law Enforcement Agency (NDLEA) facility in Lagos, on February …
Health
Experts reveal that cardiovascular diseases are the cause of nearly 28% of all deaths in India
Cardiovascular diseases are the cause of nearly 28 percent of all deaths in India. Public health datasets show this grim …
Thinking about peptides? Doctors reveal key dos and don’ts as ‘Wild West’ market grows
NEWYou can now listen to Fox News articles! The peptide boom is under scrutiny as the FDA weighs easing restrictions …
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
Pharma thinks it’s found the next frontier in preventing heart attacks. Novartis, Amgen and Eli Lilly are among the drugmakers …
Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list
The CNBC Investing Club held its April Monthly Meeting on Thursday, with Jim Cramer and Jeff Marks, director of portfolio …
More patients demand ‘unvaccinated’ blood, doctors warn of growing health risks
NEWYou can now listen to Fox News articles! An increasing number of patients are requesting “unvaccinated” blood for transfusions, which …
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on …
CNBC Cures: A father and a doctor on how raising a child with Angelman syndrome changed him
Dr. Joseph D’Orazio and his son, Gabe. Joseph D’Orazio A version of this story first appeared in the CNBC Cures …
New ‘safer opioid’ delivers pain relief without addiction risk in early tests
NEWYou can now listen to Fox News articles! An experimental medication was shown to achieve strong pain relief in early …
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t …